EM McDade - CONTINUUM: Lifelong Learning in Neurology, 2022 - journals.lww.com
Alzheimer Disease : CONTINUUM: Lifelong Learning in Neurology Account Register Activate Subscription Help Subscribe American Academy of Neurology Login Journal logo …
DF Marks, M Murray, A Locke, RA Annunziato… - 2024 - torrossa.com
Welcome to Health Psychology: Theory, Research and Practice (Seventh Edition). This textbook provides an in-depth introduction to the growing field of health psychology. It is …
D Shir, NTT Pham, H Botha, S Koga, N Kouri, F Ali… - Neurology, 2023 - AAN Enterprises
Background and Objectives Corticobasal syndrome (CBS) is a clinical phenotype characterized by asymmetric parkinsonism, rigidity, myoclonus, and apraxia. Originally …
S Wang, J Wang, J Guo, A Dove, H Xu… - The Journals of …, 2024 - academic.oup.com
Background The association between kidney function and dementia risk and the mechanisms underlying this relationship remain unclear. Methods Within the UK Biobank …
Blood-based biomarkers offer strong potential to revolutionize diagnosis, trial enrolment and treatment monitoring in Alzheimer's disease (AD). However, further advances are needed …
NM Zahr - Alcohol Research: Current Reviews, 2024 - ncbi.nlm.nih.gov
PURPOSE By 2040, 21.6% of Americans will be over age 65, and the population of those older than age 85 is estimated to reach 14.4 million. Although not causative, older age is a …
R Amland, G Selbæk, A Brækhus, TH Edwin… - Frontiers in …, 2024 - frontiersin.org
Background/aims The number of patients suffering from cognitive decline and dementia increases, and new possible treatments are being developed. Thus, the need for time …
J Kim, WR Kim, EG Park, DH Lee, YJ Lee… - International Journal of …, 2024 - mdpi.com
Dementia, a multifaceted neurological syndrome characterized by cognitive decline, poses significant challenges to daily functioning. The main causes of dementia, including …
LR Gerlach, V Prabhakaran, PG Antuono… - Acta …, 2024 - journals.sagepub.com
Background Alzheimer's disease (AD) and frontotemporal dementia (FTD) require different treatments. Since clinical presentation can be nuanced, imaging biomarkers aid in …